QCOR
Questcor Pharmaceuticals, Inc.
Last Trade: 9.84%Change:
+0.41%Volume Analysis
Average Volume: 656361
Half Hour Run Rate: 50489
1 Minute Run Rate: 1682
Run Rate Based: 655980
Current Volume: 1104743QCOR is currently rising on above average volume.
P/E: 23.67
Market Cap: 611.2M
52 Week High: 11.63
52 Week Low: 3.33
Next Year EPS: 0.79
Twitter Updates: QCOR
trademoneyideasIn
$QCOR 9.82, big volume..
StocksMDIn
$QCOR Call Spread Sept $10 and $11 calls .85 and .50 for next week.
StocksMDPicked up
$QCOR Sep 10 Calls @ .85 for next week FDA date. Gotta watch this one close, as 9/11 lands on Sat, and they may announce early
QCOR - Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. (Questcor) markets H.P. Acthar Gel (repository corticotropin injection), an injectable drug that is approved for the treatment of certain disorders with an inflammatory component, including the treatment of exacerbations associated with multiple sclerosis (MS), and the treatment of nephrotic syndrome. H.P. Acthar Gel (Acthar) is not indicated for, but is also used in treating patients with infantile spasms (IS). The Company also markets Doral (quazepam), which is indicated for the treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. As of December 31, 2008, Acthar was approved in the United States for the treatment of exacerbations associated with MS, nephrotic syndrome and many other conditions with an inflammatory component.
Reply!
Retweet!